These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16276126)

  • 1. The implications of the Medicare Modernization Act for dual eligibles.
    Deshpande M
    Am J Geriatr Cardiol; 2005; 14(6):298-300. PubMed ID: 16276126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What does the Medicare prescription drug legislation mean for the American cardiologist?
    Schwartz JB; Redberg RF
    Am J Geriatr Cardiol; 2005; 14(6):317-24. PubMed ID: 16276130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Dec; 68(240):69839-927. PubMed ID: 14674398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Medicare Part D drug benefit: lessons from the experience with drug discount cards.
    Doering PL
    Am J Geriatr Cardiol; 2005; 14(6):308-12. PubMed ID: 16276128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicare program; establishment of the Medicare advantage program. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4587-741. PubMed ID: 15678604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State Medicaid prescription drug expenditures for Medicare-Medicaid dual eligibles: estimates of Medicaid savings and federal expenditures resulting from expanded Medicare prescription coverage.
    Dale SB; Verdier JM
    Issue Brief (Commonw Fund); 2003 Apr; (627):1-12. PubMed ID: 12685428
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of the Medicare prescription drug benefit on home- and community-based services waiver programs.
    Milligan CJ
    Issue Brief (Commonw Fund); 2005 Apr; (815):1-8. PubMed ID: 15856612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicare Part D: successes and continuing challenges. Impact of Medicare Part D on Massachusetts health programs and beneficiaries.
    Thomas CP; Sussman J; ;
    Issue Brief (Mass Health Policy Forum); 2007 May; (32):1-32. PubMed ID: 17546802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transition to Medicare Part D: an early snapshot of barriers experienced by younger dual eligibles with disabilities.
    Hall JP; Kurth NK; Moore JM
    Am J Manag Care; 2007 Jan; 13(1):14-8. PubMed ID: 17227199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Medicare Prescription Drug Improvement and Modernization Act: prescription drugs and academic medicine.
    Frencher SK; Glied S
    Acad Med; 2006 Sep; 81(9):812-6. PubMed ID: 16936488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Medicare Prescription Drug, Improvement and Modernization Act and the impact on care of people with chronic illness: benefit design and implementation issues.
    Schlosberg C
    Care Manag J; 2004; 5(2):113-21. PubMed ID: 16047917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6.4 million at risk: protecting the poorest Americans during the Medicare drug transition.
    Medicare Rights Center
    Care Manag J; 2005; 6(3):151-8. PubMed ID: 16642690
    [No Abstract]   [Full Text] [Related]  

  • 14. Explosion in the medicine chest.
    Zarabozo C
    Health Care Financ Rev; 1999; 20(3):1-13. PubMed ID: 10558014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementing the Medicare drug benefit in a diverse inner-city community.
    Stubbings J; Durley SF; Lin SJ; Kliethermes M; Aruru MD; Evangelista C; Byun M
    Am J Health Syst Pharm; 2007 Jan; 64(2):193-9. PubMed ID: 17215471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicare Part D: selected issues for pharmacists and beneficiaries in 2007.
    Kilian J; Stubbings J
    J Manag Care Pharm; 2007; 13(1):59-65. PubMed ID: 17269838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Medicare Prescription Drug, Improvement, and Modernization Act of 2003.
    Emmer S; Allendorf L
    J Am Geriatr Soc; 2004 Jun; 52(6):1013-5. PubMed ID: 15161471
    [No Abstract]   [Full Text] [Related]  

  • 18. How beneficiaries fare under the new Medicare drug bill.
    Moon M
    Issue Brief (Commonw Fund); 2004 Jun; (730):1-16. PubMed ID: 15176395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in reimbursement rates and rules associated with the Medicare Prescription Drug Improvement and Modernization Act. Introduction.
    Johnson PE
    Am J Health Syst Pharm; 2006 Nov; 63(21 Suppl 7):S2-6. PubMed ID: 17057057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicare program: Medicare Advantage and Prescription Drug Benefit programs: final marketing provisions. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2008 Sep; 73(182):54207-23. PubMed ID: 18985950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.